BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2281107)

  • 1. Radiolabeled antibodies specific for human blood elements.
    Thakur ML; DeFulvio J
    Prog Clin Biol Res; 1990; 355():281-92. PubMed ID: 2281107
    [No Abstract]   [Full Text] [Related]  

  • 2. Technetium-99m labeled monoclonal antibodies: evaluation of reducing agents.
    Thakur ML; DeFulvio J; Richard MD; Park CH
    Int J Rad Appl Instrum B; 1991; 18(2):227-33. PubMed ID: 2026499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of reduced disulfide groups in monoclonal antibodies.
    Thakur ML; DeFulvio JD
    Biotechniques; 1990 May; 8(5):512-6. PubMed ID: 2357374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved protein labeling by stannous tartrate reduction of pertechnetate.
    Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
    J Nucl Med; 1980 Jan; 21(1):59-62. PubMed ID: 7356741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte labeling with technetium-99m tin colloids.
    Hanna R; Lomas F; Sullivan P
    J Nucl Med; 1988 May; 29(5):729-30. PubMed ID: 3373309
    [No Abstract]   [Full Text] [Related]  

  • 6. Disulfide bond-targeted radiolabeling: tumor specificity of a streptavidin-biotinylated monoclonal antibody complex.
    del Rosario RB; Wahl RL
    Cancer Res; 1990 Feb; 50(3 Suppl):804s-808s. PubMed ID: 2297728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody radiolabeling with technetium-99m].
    Perera A; Pérez C
    Rev Esp Med Nucl; 1998; 17(4):302-9. PubMed ID: 9721347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and properties of antitumor monoclonal antibodies labeled with metallic radionuclides indium-111, gallium-67, and technetium-99m.
    Endo K; Sakahara H; Nakashima T; Koizumi M; Ohta H; Kawamura Y; Kunimatsu M; Furukawa T; Ohmomo Y; Arano Y
    NCI Monogr; 1987; (3):135-40. PubMed ID: 3469526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled monoclonal antibodies for cancer therapy and diagnosis: is it really a chimera?
    Sands H
    J Nucl Med; 1992 Jan; 33(1):29-32. PubMed ID: 1730992
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantifying inflammation in vivo using radiolabeled antibodies and leukocytes.
    Marshall D; Haskard DO
    Methods Mol Biol; 2003; 225():273-82. PubMed ID: 12769495
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of radiolabeled human and mouse monoclonal IgM antibodies in murine models.
    Halpern SE; Hagan PL; Chen A; Birdwell CR; Bartholomew RM; Burnett KG; David GS; Poggenburg K; Merchant B; Carlo DJ
    J Nucl Med; 1988 Oct; 29(10):1688-96. PubMed ID: 3171697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
    Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
    J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte kinetics and methods of evaluating cell performance.
    Peters AM
    Nucl Med Commun; 1988 Oct; 9(10):687-92. PubMed ID: 3062506
    [No Abstract]   [Full Text] [Related]  

  • 16. Splenic blood flow and blood cell kinetics.
    Peters AM
    Clin Haematol; 1983 Jun; 12(2):421-47. PubMed ID: 6352111
    [No Abstract]   [Full Text] [Related]  

  • 17. Ascorbate plays a major role in labeling proteins with technetium-99m.
    Thakur ML
    J Nucl Med; 1994 Sep; 35(9):1566-8. PubMed ID: 8071714
    [No Abstract]   [Full Text] [Related]  

  • 18. Labeling of monoclonal antibodies with samarium-153 for combined radioimmunoscintigraphy and radioimmunotherapy.
    Boniface GR; Izard ME; Walker KZ; McKay DR; Sorby PJ; Turner JH; Morris JG
    J Nucl Med; 1989 May; 30(5):683-91. PubMed ID: 2785586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computer program for quantification of SH groups generated after reduction of monoclonal antibodies.
    Iznaga Escobar N; Morales A; Núñez G
    Nucl Med Biol; 1996 Jul; 23(5):635-9. PubMed ID: 8905829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of reduction-mediated labelling of antibodies with technetium-99m.
    Zhang ZM; Ballinger JR; Sheldon K; Boxen I
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):607-9. PubMed ID: 1522015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.